Metraipolis › archive › dc_a74abb5294b5

Use of low-dose immune checkpoint inhibitors in low- and middle-income countries: a national survey of oncologists and hematologists in Mexico — Europe PMC PMID:42437063

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42437063
DOI
10.3332/ecancer.2026.2144
License (as archived)
solo-consultazione
Archived
2026-10-31T14:30:15.405Z
SHA-256 of the archived text
b6108117f4b3e37c8decef3d7365b9e39d9b19349dc76f20fbc6b744cc3dc383
Stable URL of this page
https://metraipolis.com/documento/dc_a74abb5294b5

How to cite

Use of low-dose immune checkpoint inhibitors in low- and middle-income countries: a national survey of oncologists and hematologists in Mexico — Europe PMC PMID:42437063 — Europe PMC (en), https://europepmc.org/article/MED/42437063 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a74abb5294b5 (Metraipolis archive dc_a74abb5294b5, sha256 b6108117f4b3e37c8decef3d7365b9e39d9b19349dc76f20fbc6b744cc3dc383)
BibTeX
@misc{dca74abb5294b5,
  title = {Use of low-dose immune checkpoint inhibitors in low- and middle-income countries: a national survey of oncologists and hematologists in Mexico — Europe PMC PMID:42437063},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42437063},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a74abb5294b5; sha256 b6108117f4b3e37c8decef3d7365b9e39d9b19349dc76f20fbc6b744cc3dc383},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42437063. Agents can read the archived copy with the MCP tool read_document.